dc.contributor.author | CALANGU, S | |
dc.contributor.author | AYGEN, B | |
dc.contributor.author | TURGUT, H | |
dc.contributor.author | BAKIR, M | |
dc.contributor.author | DOGANAY, M | |
dc.date.accessioned | 2021-03-03T07:35:08Z | |
dc.date.available | 2021-03-03T07:35:08Z | |
dc.date.issued | 1995 | |
dc.identifier.citation | DOGANAY M., CALANGU S., TURGUT H., BAKIR M., AYGEN B., "TREATMENT OF TUBERCULOUS MENINGITIS IN TURKEY", SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, cilt.27, sa.2, ss.135-138, 1995 | |
dc.identifier.issn | 0036-5548 | |
dc.identifier.other | av_12b9338e-b5e9-4176-afaf-d58481be2f3a | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/18035 | |
dc.identifier.uri | https://doi.org/10.3109/00365549509018993 | |
dc.description.abstract | A prospective study was performed on 72 cases of tuberculous meningitis studying various treatments. 37 patients were treated with a combination of isoniazid, rifampicin, pyrazinamide and streptomycin for 2 months, followed by a combination of isoniazid and rifampicin for 6 months. 35 patients were treated with various combinations of antituberculous drugs for 12-16 months. Disappearance of symptoms took (mean) 17 days. Mean duration of therapy for the hospitalized patients was 36 +/- 4 days. Seven (9.7%) patients died, 5 in the short-course therapy group and 2 in the long-course therapy group. Sequelae persisted in 18 (31%) cases, 8 of which cases were in the short-course therapy group and 10 in the long-course therapy group. No relapse was observed in either of the groups. | |
dc.language.iso | eng | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Temel Bilimler | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.subject | İmmünoloji | |
dc.subject | Yaşam Bilimleri | |
dc.title | TREATMENT OF TUBERCULOUS MENINGITIS IN TURKEY | |
dc.type | Makale | |
dc.relation.journal | SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | |
dc.contributor.department | , , | |
dc.identifier.volume | 27 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 135 | |
dc.identifier.endpage | 138 | |
dc.contributor.firstauthorID | 115993 | |